Drugs / SC401B
last change Dec 2014 re-read 3 minutes ago

SC401B

Investigated by
Sancilio and Company, Inc.

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01997268 ? → Dec 2014 — Sancilio and Company, Inc. Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SC401B ClinicalTrials.gov intervention name — accepted as the source's own label NCT01997268 ↗